Mallinckrodt plc, specialty pharmaceutical company, has closed the sale of Recothrom Thrombin topical (Recombinant) and Preveleak Surgical Sealant to Baxter International Inc.. “This action further illustrates the strategic evolution of our portfolio, and will free resources for investing in treatments for seriously ill infants and adults,” said Mark Trudeau, president and CEO of Mallinckrodt. “We believe these products are an excellent fit…